| Authors: |
Wu CY; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada., Sharma A; Division of Cardiology, McGill University Health Centre, McGill University, Montreal, QC, Canada.; DREAM-CV Lab, McGill University Health Centre, McGill University, Montreal, QC, Canada., Edwards JD; University of Ottawa Heart Institute, University of Ottawa, Ottawa, ON, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; ICES uOttawa, Ottawa, ON, Canada., Liu PP; University of Ottawa Heart Institute, University of Ottawa, Ottawa, ON, Canada., Kapral MK; ICES, Toronto, ON, Canada.; Division of General Internal Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada., Herrmann N; Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Wu CF; ICES, Toronto, ON, Canada., Podolsky S; ICES, Toronto, ON, Canada., Swardfager W; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. w.swardfager@utoronto.ca.; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada. w.swardfager@utoronto.ca.; KITE University Health Network Toronto Rehabilitation Institute, Toronto, ON, Canada. w.swardfager@utoronto.ca., Shah BR; ICES, Toronto, ON, Canada.; Division of Endocrinology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada. |